Skip to content
easybpt
Browse topics

Nephrology

Hypertension in kidney disease

Renal parenchymal and renovascular hypertension, BP targets and drug choice across CKD, dialysis and transplant, and the renal emergencies where the right antihypertensive matters (scleroderma renal crisis).

Tier 1Condition

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions9 flashcards

At a glance

  • Kidney disease is the commonest secondary cause of hypertension, and in Australia and NZ hypertension and renovascular disease are the third commonest cause of kidney failure, after diabetes and glomerulonephritis (ANZDATA; hypertension ranks second in US data). Each worsens the other.
  • Renal parenchymal hypertension comes from sodium retention, RAAS activation and sympathetic overactivity. It affects most people with CKD G4 and nearly everyone on dialysis.
  • Renovascular hypertension is atherosclerotic in about 90% (older, vascular disease) and fibromuscular dysplasia in most of the rest (mostly women, from young adulthood to middle age).

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions9 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Turnstile bot check on sign-in and signed-out feedback

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.